Profectus Biosciences Inc., a Baltimore HIV and cancer research company, will add 20 local jobs by 2009 and could be awarded more federal funding to expand its development of vaccines.
Profectus Biosciences Inc., a Baltimore HIV and cancer research company, will add 20 local jobs by 2009 and could be awarded more federal funding to expand its development of vaccines.
